{"count": 14, "results": [{"_id": "40932867", "pmid": 40932867, "title": "Correlation between metformin use and mortality in acute respiratory failure: a retrospective ICU cohort study.", "journal": "Front Pharmacol", "authors": ["Yang Y", "Liu J", "Hou Y", "Wei Y", "Huang L", "Wei W"], "date": "2025-08-26T00:00:00Z", "doi": "10.3389/fphar.2025.1584230", "meta_date_publication": "2025", "meta_volume": "16", "meta_issue": "", "meta_pages": "1584230", "score": 50263.465, "text_hl": "Correlation between @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use and mortality in @<m>DISEASE_Respiratory_Insufficiency</m> @DISEASE_MESH:D012131 @@@acute respiratory failure@@@: a retrospective ICU cohort study.", "citations": {"NLM": "Yang Y, Liu J, Hou Y, Wei Y, Huang L, Wei W. Correlation between metformin use and mortality in acute respiratory failure: a retrospective ICU cohort study. Front Pharmacol. 2025;16():1584230. PMID: 40932867", "BibTeX": "@article{40932867, title={Correlation between metformin use and mortality in acute respiratory failure: a retrospective ICU cohort study.}, author={Yang Y and Liu J and Hou Y and Wei Y and Huang L and Wei W}, journal={Front Pharmacol}, volume={16}, pages={1584230}}"}}, {"_id": "34966196", "pmid": 34966196, "pmcid": "PMC8666492", "title": "Association Between Metformin Use and Mortality among Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19 Infection", "journal": "J ASEAN Fed Endocr Soc", "authors": ["Ong AN", "Tan CC", "Cañete MT", "Lim BA", "Robles J"], "date": "2021-01-01T00:00:00Z", "doi": "10.15605/jafes.036.02.20", "meta_date_publication": "2021", "meta_volume": "36", "meta_issue": "2", "meta_pages": "133-141", "score": 50254.61, "text_hl": "We categorized @SPECIES_9606 @@@patients@@@ as to use or non-use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, subdividing the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group into home @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ users, in-hospital @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ users, and mixed home/in-hospital @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ users. ", "citations": {"NLM": "Ong AN, Tan CC, Cañete MT, Lim BA, Robles J. Association Between Metformin Use and Mortality among Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19 Infection J ASEAN Fed Endocr Soc. 2021;36(2):133-141. PMID: 34966196", "BibTeX": "@article{34966196, title={Association Between Metformin Use and Mortality among Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19 Infection}, author={Ong AN and Tan CC and Cañete MT and Lim BA and Robles J}, journal={J ASEAN Fed Endocr Soc}, volume={36}, number={2}, pages={133-141}}"}}, {"_id": "35297689", "pmid": 35297689, "title": "Lung and chest wall mechanical properties in metformin-treated and untreated models of type 2 diabetes.", "journal": "J Appl Physiol (1985)", "authors": ["Schranc Á", "Fodor GH", "Südy R", "Ballók B", "Kulcsár R", "Tolnai J", "Babik B", "Peták F"], "date": "2022-05-01T00:00:00Z", "doi": "10.1152/japplphysiol.00724.2021", "meta_date_publication": "2022 May 1", "meta_volume": "132", "meta_issue": "5", "meta_pages": "1115-1124", "score": 50251.484, "text_hl": "The adequacy of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ to treat the adverse @<m>DISEASE_Respiratory_Insufficiency</m> @DISEASE_MESH:D012131 @@@respiratory@@@ consequences of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ was also revealed, in addition to its well-established beneficial effects on other organs.NEW & NOTEWORTHY The present study examined the contributions of the lungs and chest wall to @DISEASE_Respiratory_Tract_Diseases @DISEASE_MESH:D012140 @@@respiratory complications@@@ in a @SPECIES_10116 @@@rat@@@ model of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ and clarified the effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on these changes. ", "citations": {"NLM": "Schranc Á, Fodor GH, Südy R, Ballók B, Kulcsár R, Tolnai J, Babik B, Peták F. Lung and chest wall mechanical properties in metformin-treated and untreated models of type 2 diabetes. J Appl Physiol (1985). 2022 May 1;132(5):1115-1124. PMID: 35297689", "BibTeX": "@article{35297689, title={Lung and chest wall mechanical properties in metformin-treated and untreated models of type 2 diabetes.}, author={Schranc Á and Fodor GH and Südy R and Ballók B and Kulcsár R and Tolnai J and Babik B and Peták F}, journal={J Appl Physiol (1985)}, volume={132}, number={5}, pages={1115-1124}}"}}, {"_id": "33139960", "pmid": 33139960, "title": "Loss of metabolic plasticity underlies metformin toxicity in aged Caenorhabditis elegans.", "journal": "Nat Metab", "authors": ["Espada L", "Dakhovnik A", "Chaudhari P", "Martirosyan A", "Miek L", "Poliezhaieva T", "Schaub Y", "Nair A", "Döring N", "Rahnis N", "Werz O", "Koeberle A", "Kirkpatrick J", "Ori A", "Ermolaeva MA"], "date": "2020-11-01T00:00:00Z", "doi": "10.1038/s42255-020-00307-1", "meta_date_publication": "2020 Nov", "meta_volume": "2", "meta_issue": "11", "meta_pages": "1316-1331", "score": 50247.305, "text_hl": "We find that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ exacerbates ageing-associated @DISEASE_Mitochondrial_Diseases @DISEASE_MESH:D028361 @@@mitochondrial dysfunction@@@, causing @<m>DISEASE_Respiratory_Insufficiency</m> @DISEASE_MESH:D012131 @@@respiratory failure@@@. ", "citations": {"NLM": "Espada L, Dakhovnik A, Chaudhari P, Martirosyan A, Miek L, Poliezhaieva T, Schaub Y, Nair A, Döring N, Rahnis N, Werz O, Koeberle A, Kirkpatrick J, Ori A, Ermolaeva MA. Loss of metabolic plasticity underlies metformin toxicity in aged Caenorhabditis elegans. Nat Metab. 2020 Nov;2(11):1316-1331. PMID: 33139960", "BibTeX": "@article{33139960, title={Loss of metabolic plasticity underlies metformin toxicity in aged Caenorhabditis elegans.}, author={Espada L and Dakhovnik A and Chaudhari P and Martirosyan A and Miek L and Poliezhaieva T and Schaub Y and Nair A and Döring N and Rahnis N and Werz O and Koeberle A and Kirkpatrick J and Ori A and Ermolaeva MA}, journal={Nat Metab}, volume={2}, number={11}, pages={1316-1331}}"}}, {"_id": "33015023", "pmid": 33015023, "pmcid": "PMC7498539", "title": "Nano-Platelets as an Oxygen Regulator for Augmenting Starvation Therapy Against Hypoxic Tumor", "journal": "Front Bioeng Biotechnol", "authors": ["Huang C", "Zhu C", "Chen J", "Huang K", "Li F", "Ding S", "Xia L", "Jiang W", "Li Y"], "date": "2020-09-04T00:00:00Z", "doi": "10.3389/fbioe.2020.571993", "meta_date_publication": "2020", "meta_volume": "8", "meta_issue": "", "meta_pages": "571993", "score": 50247.016, "text_hl": "Here, we describe the design and testing of a platelet membrane mimetic, @CHEMICAL_Promethium @CHEMICAL_MESH:D011399 @@@PMS@@@, consisting of mesoporous silica nanoparticles (MSNs) loaded with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@MET@@@) as an inner layer and platelet membranes (PM) as an outer layer that inhibits @CHEMICAL_Oxygen @CHEMICAL_MESH:D010100 @@@oxygen@@@ consumption by the @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@tumor@@@ cells' @<m>DISEASE_Respiratory_Insufficiency</m> @DISEASE_MESH:D012131 @@@respiratory@@@ pathways and enhances the effectiveness of @GENE_HAO1 @GENE_15112 @@@GOx@@@. ", "citations": {"NLM": "Huang C, Zhu C, Chen J, Huang K, Li F, Ding S, Xia L, Jiang W, Li Y. Nano-Platelets as an Oxygen Regulator for Augmenting Starvation Therapy Against Hypoxic Tumor Front Bioeng Biotechnol. 2020;8():571993. PMID: 33015023", "BibTeX": "@article{33015023, title={Nano-Platelets as an Oxygen Regulator for Augmenting Starvation Therapy Against Hypoxic Tumor}, author={Huang C and Zhu C and Chen J and Huang K and Li F and Ding S and Xia L and Jiang W and Li Y}, journal={Front Bioeng Biotechnol}, volume={8}, pages={571993}}"}}, {"_id": "21467829", "pmid": 21467829, "title": "Perioperative use of metformin in cardiac surgery.", "journal": "Medicina (Kaunas)", "authors": ["Sirvinskas E", "Kinduris S", "Kapturauskas J", "Samalavičius R"], "date": "2010-01-01T00:00:00Z", "meta_date_publication": "2010", "meta_volume": "46", "meta_issue": "11", "meta_pages": "723-9", "score": 50054.914, "text_hl": "Concerns have been raised for the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Respiratory_Insufficiency</m> @DISEASE_MESH:D012131 @@@cardiovascular, renal, hepatic, and respiratory failure@@@. ", "citations": {"NLM": "Sirvinskas E, Kinduris S, Kapturauskas J, Samalavičius R. Perioperative use of metformin in cardiac surgery. Medicina (Kaunas). 2010;46(11):723-9. PMID: 21467829", "BibTeX": "@article{21467829, title={Perioperative use of metformin in cardiac surgery.}, author={Sirvinskas E and Kinduris S and Kapturauskas J and Samalavičius R}, journal={Medicina (Kaunas)}, volume={46}, number={11}, pages={723-9}}"}}, {"_id": "10477216", "pmid": 10477216, "title": "Contra-indications to metformin therapy are largely disregarded.", "journal": "Diabet Med", "authors": ["Holstein A", "Nahrwold D", "Hinze S", "Egberts EH"], "date": "1999-08-01T00:00:00Z", "doi": "10.1046/j.1464-5491.1999.00115.x", "meta_date_publication": "1999 Aug", "meta_volume": "16", "meta_issue": "8", "meta_pages": "692-6", "score": 50053.246, "text_hl": "As major contra-indications to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @DISEASE_Kidney_Diseases @DISEASE_MESH:D007674 @@@renal impairment@@@ was present in 19% of all @SPECIES_9606 @@@patients@@@, @DISEASE_Heart_Failure @DISEASE_MESH:D006333 @@@heart failure@@@ in 25%, @<m>DISEASE_Respiratory_Insufficiency</m> @DISEASE_MESH:D012131 @@@respiratory insufficiency@@@ in 6.5%, and @DISEASE_Liver_Diseases @DISEASE_MESH:D008107 @@@hepatic impairment@@@ in 1.3%. ", "citations": {"NLM": "Holstein A, Nahrwold D, Hinze S, Egberts EH. Contra-indications to metformin therapy are largely disregarded. Diabet Med. 1999 Aug;16(8):692-6. PMID: 10477216", "BibTeX": "@article{10477216, title={Contra-indications to metformin therapy are largely disregarded.}, author={Holstein A and Nahrwold D and Hinze S and Egberts EH}, journal={Diabet Med}, volume={16}, number={8}, pages={692-6}}"}}, {"_id": "20393934", "pmid": 20393934, "title": "Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.", "journal": "Cochrane Database Syst Rev", "authors": ["Salpeter SR", "Greyber E", "Pasternak GA", "Salpeter EE"], "date": "2010-04-14T00:00:00Z", "doi": "10.1002/14651858.CD002967.pub4", "meta_date_publication": "2010 Apr 14", "meta_volume": "2010", "meta_issue": "4", "meta_pages": "CD002967", "score": 50040.586, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, however, is thought to increase the risk of @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@, and has been considered to be contraindicated in many chronic @<m>DISEASE_Respiratory_Insufficiency</m> @DISEASE_MESH:D012131 @@@hypoxemic@@@ conditions that may be associated with @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@, such as @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular, renal, hepatic and pulmonary disease@@@, and advancing age. ", "citations": {"NLM": "Salpeter SR, Greyber E, Pasternak GA, Salpeter EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010 Apr 14;2010(4):CD002967. PMID: 20393934", "BibTeX": "@article{20393934, title={Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.}, author={Salpeter SR and Greyber E and Pasternak GA and Salpeter EE}, journal={Cochrane Database Syst Rev}, volume={2010}, number={4}, pages={CD002967}}"}}, {"_id": "20091535", "pmid": 20091535, "title": "Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.", "journal": "Cochrane Database Syst Rev", "authors": ["Salpeter SR", "Greyber E", "Pasternak GA", "Salpeter Posthumous EE"], "date": "2010-01-20T00:00:00Z", "doi": "10.1002/14651858.CD002967.pub3", "meta_date_publication": "2010 Jan 20", "meta_volume": "", "meta_issue": "1", "meta_pages": "CD002967", "score": 50040.465, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, however, is thought to increase the risk of @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@, and has been considered to be contraindicated in many chronic @<m>DISEASE_Respiratory_Insufficiency</m> @DISEASE_MESH:D012131 @@@hypoxemic@@@ conditions that may be associated with @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@, such as @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular, renal, hepatic and pulmonary disease@@@, and advancing age. ", "citations": {"NLM": "Salpeter SR, Greyber E, Pasternak GA, Salpeter Posthumous EE. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD002967. PMID: 20091535", "BibTeX": "@article{20091535, title={Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.}, author={Salpeter SR and Greyber E and Pasternak GA and Salpeter Posthumous EE}, journal={Cochrane Database Syst Rev}, number={1}, pages={CD002967}}"}}, {"_id": "12076461", "pmid": 12076461, "title": "Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.", "journal": "Cochrane Database Syst Rev", "authors": ["Salpeter S", "Greyber E", "Pasternak G", "Salpeter E"], "date": "2002-01-01T00:00:00Z", "doi": "10.1002/14651858.CD002967", "meta_date_publication": "2002", "meta_volume": "", "meta_issue": "2", "meta_pages": "CD002967", "score": 50038.785, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, however, is thought to increase the risk of @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@, and is considered to be contraindicated in many chronic @<m>DISEASE_Respiratory_Insufficiency</m> @DISEASE_MESH:D012131 @@@hypoxemic@@@ conditions that may be associated with @DISEASE_Acidosis_Lactic @DISEASE_MESH:D000140 @@@lactic acidosis@@@, such as @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular, renal, hepatic and pulmonary disease@@@, and advancing age. ", "citations": {"NLM": "Salpeter S, Greyber E, Pasternak G, Salpeter E. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev. 2002;(2):CD002967. PMID: 12076461", "BibTeX": "@article{12076461, title={Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.}, author={Salpeter S and Greyber E and Pasternak G and Salpeter E}, journal={Cochrane Database Syst Rev}, number={2}, pages={CD002967}}"}}]}